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Cahill LE, Chiuve SE, Mekary RA, et al. Circulation 2013;128:337-43
Conclusions: Eating breakfast is associated with signiﬁcantly lower
coronary heart disease risk in a cohort of male health professionals.
Summary: It is commonly stated breakfast is the most important
meal of the day. There are, however, no evidence-based recommendations
for adults in terms of eating habits. The 2002 National Health and Nutri-
tion Examination Survey found that 18% of Americans skip breakfast and
86% snack during the day (Kant AK, Graubard BI, Am J Clin Nutr
2006;84:1215-23). However, preliminary cross-sectional studies and small
prospective studies suggest some eating habits, such as skipping meals, are
associated with adverse cardiometabolic health outcomes such as over-
weight, weight gain, dyslipidemia, insulin sensitivity, and diabetes (van
der Heijden AA et al, Obesity 2007;15:2463-9; and Jenkins DJ, N Engl
J Med, 1989;321:929-34). Previously, there have not been human studies
of eating habits in coronary heart disease. The objective of this study was
to prospectively determine any relationship between eating habits,
including skipping breakfast, and possible relationships to rates of coronary
heart disease. Eating habits were assessed in 1992 in 26,902 American men
age 45 to 82 years in the Health Professionals Follow-up Study. All sub-
jects were initially free of known cardiovascular disease and cancer. The
Health Professionals Follow-up Study is a prospective study of 51,529
male health professionals (dentists, veterinarians, pharmacists, optometrists,
osteopaths, and podiatrists) aged 40 to 75 years at enrollment in 1986.
About 97% of participants are of white European decent. Follow-up has
been through mailed biennial questionnaires ascertaining medical history,
lifestyle, and health-related behaviors. During 16 years of follow-up,
1527 incident coronary heart disease cases have been diagnosed. Cox
proportional hazards models were used to estimate relative risks and 95%
conﬁdence intervals (CIs) for coronary heart disease. Data are adjusted
for demographic, diet, lifestyle, and other coronary heart disease risk fac-
tors. Men who skipped breakfast had a 27% higher risk of coronary heart
disease compared with men who did not (relative risk, 1.27; 95% CI,
1.06-1.53). Compared with men who did not eat late at night, those
who ate late at night had a 55% higher coronary heart disease risk (relative
risk, 1.55; 95% CI, 1.05-2.29). Associations were mediated by body mass
index, hypertension, hypercholesterolemia, and diabetes mellitus. No asso-
ciation was observed between eating frequency (times per day) and risk of
coronary heart disease.
Comment: It is known omitting breakfast impairs serum lipid and
postprandial insulin sensitivity (Farshchi HR et al, Am J Clin Nutr
2005;81:388-96). This study extends such basic metabolic observations
to more clinically relevant clinical end points. The study indicates the beneﬁt
of breakfast consumption for prevention of coronary events. On the basis of
the data here, further studies are obviously needed, but the current data
would support a recommendation of daily breakfast eating by males in
health professions to help prevent coronary heart disease and improve indi-
vidual and population health levels.Reduction in Early Stroke Risk in Carotid Stenosis With Transient
Ischemic Attack Associated With Statin Treatment
Merwick Á, Albers GW, Arsava EM, et al. Stroke 2013;44:2814-20.
Conclusions: In patients with acute symptomatic carotid stenosis,
statin pretreatment is associated with reduced stroke risk.
Summary: Carotid endarterectomy (CEA) in patients with associated
symptoms is highly effective for secondary stroke prevention. Maximum
beneﬁt appears to be in those who undergo surgery #2 weeks of symptom
onset; however, the safety of very early CEA has been questioned. Data
from the Swedish Vascular Registry indicated an 11.5% stroke and death
rate in patients undergoing CEA #48 hours of symptom onset. This is a
fourfold increase in the odds of a poor outcome compared with those un-
dergoing CEA from 3 to 7 days (Strömberg S et al, Stroke
2012;43:1331-5). In patients with acute coronary syndromes, statin medi-
cations appear beneﬁcial for secondary vascular prevention secondary to
their plaque-stabilizing effects. There are, however, few data for patients
with unstable carotid stenosis addressing early stroke recurrence and statin
pretreatment at the time of symptoms or statins begun acutely after symp-
toms. The authors hypothesize that statin pretreatment at transient ischemic
attack (TIA) onset would be associated with reduced early stroke risk in
patients with TIA and carotid stenosis and that this would include those
awaiting CEA. The authors analyze data from 2770 patients with TIAs
from 11 centers; 387 had ipsilateral carotid stenosis. ABCD2 (age $60
years; blood pressure $140/90 mmHg at initial evaluation; clinical features
of the TIA; duration of symptoms, and diabetes mellitus) scores, diffusion-
weighted imaging results, medication pretreatment, and early stroke were
recorded. In patients with carotid stenosis, the 7-day stroke risk was 8.3%
(95% CI, 5.7%-11.1%) compared with 2.7% (95% CI, 2.0%-3.4%) in patients
without carotid stenosis (P < .0001). The 90-day stroke risk was also
increased in patients with carotid stenosis (7.8% vs 5.7%; P < .0001). In pa-
tients with carotid stenosis, the nonprocedural 7-day stroke risk was 3.8%
(95% CI, 1.2%-9.7%) with statin treatment at TIA onset. This was compared
with 13.2% (95% CI, 8.5%-19.8%) in those not pretreated with statin (P ¼
.01), with a 90-day risk of 8.9% vs 20.8% (P ¼ .01). Statin pretreatment was
associated with reduced stroke risk in patients with carotid stenosis (odds
ratio for a 90-day stroke, 0.37; 95% CI, 0.17-0.82) but not with nonstenosis
patients (odds ratio, 1.3; 95% CI, 0.8-2.24). Association with reduced
stroke risk with statin pretreatment remained with multivariable logistic
regression adjusted for ABCD2 scores, smoking, antiplatelet treatment,
recent TIA, and diffusion-weighted imaging hyperintensity (adjusted P for
interaction ¼ .054).
Comment: The data indicate that in patients with TIAs and carotid
stenosis, who do not undergo an early procedure, stroke risk is reduced
with pretreatment with statins at the time of TIA onset. Given the contro-
versy involving very early CEA induced by the data from the Swedish
Vascular Registry, clinicians electing not to perform very early CEA in pa-
tients with recently symptomatic carotid stenosis may be able to reduce early
stroke risk in those not subject to CEA by ensuring that their patients are on
a statin medication.
